Adel Younoszai
Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fontan Procedure | 11 | 2020 | 200 | 1.980 |
Why?
| | Heart Ventricles | 12 | 2026 | 767 | 1.610 |
Why?
| | Heart Defects, Congenital | 13 | 2026 | 941 | 1.590 |
Why?
| | Echocardiography | 15 | 2019 | 652 | 1.150 |
Why?
| | Ventricular Function, Left | 10 | 2018 | 546 | 0.970 |
Why?
| | Hypoplastic Left Heart Syndrome | 5 | 2020 | 120 | 0.920 |
Why?
| | Hypertension, Pulmonary | 9 | 2019 | 1977 | 0.740 |
Why?
| | Cardiac Catheterization | 10 | 2019 | 572 | 0.710 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2016 | 394 | 0.690 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 322 | 0.610 |
Why?
| | Echocardiography, Doppler | 3 | 2017 | 118 | 0.550 |
Why?
| | Heart Bypass, Right | 2 | 2018 | 17 | 0.550 |
Why?
| | Outpatients | 1 | 2022 | 450 | 0.550 |
Why?
| | Postoperative Complications | 7 | 2020 | 3022 | 0.550 |
Why?
| | Tricuspid Valve | 2 | 2017 | 43 | 0.520 |
Why?
| | Pulmonary Artery | 9 | 2020 | 1132 | 0.510 |
Why?
| | Ambulatory Care | 1 | 2022 | 625 | 0.500 |
Why?
| | Critical Pathways | 1 | 2018 | 111 | 0.500 |
Why?
| | Heart Failure, Systolic | 1 | 2017 | 26 | 0.500 |
Why?
| | Myocardial Ischemia | 3 | 2014 | 287 | 0.480 |
Why?
| | Forecasting | 1 | 2018 | 391 | 0.470 |
Why?
| | Stroke Volume | 6 | 2020 | 658 | 0.450 |
Why?
| | Torsion Abnormality | 1 | 2014 | 20 | 0.430 |
Why?
| | Heart Block | 1 | 2014 | 41 | 0.430 |
Why?
| | Myocardial Contraction | 5 | 2020 | 293 | 0.420 |
Why?
| | Risk Assessment | 6 | 2018 | 3784 | 0.410 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2014 | 24 | 0.400 |
Why?
| | Child | 32 | 2026 | 22980 | 0.400 |
Why?
| | Altitude | 1 | 2018 | 471 | 0.390 |
Why?
| | Palliative Care | 2 | 2019 | 1032 | 0.390 |
Why?
| | Elasticity Imaging Techniques | 2 | 2018 | 59 | 0.370 |
Why?
| | Hemodynamics | 5 | 2020 | 1127 | 0.350 |
Why?
| | Case-Control Studies | 10 | 2018 | 3660 | 0.340 |
Why?
| | Ventricular Function, Right | 4 | 2019 | 300 | 0.330 |
Why?
| | Bronchopulmonary Dysplasia | 4 | 2019 | 437 | 0.300 |
Why?
| | Systole | 5 | 2017 | 181 | 0.300 |
Why?
| | Vascular Diseases | 3 | 2017 | 252 | 0.290 |
Why?
| | Echocardiography, Doppler, Pulsed | 4 | 2016 | 14 | 0.280 |
Why?
| | Diastole | 7 | 2018 | 147 | 0.280 |
Why?
| | Coronary Vessels | 4 | 2017 | 246 | 0.280 |
Why?
| | Child, Preschool | 17 | 2026 | 12017 | 0.280 |
Why?
| | Male | 40 | 2026 | 73954 | 0.270 |
Why?
| | Retrospective Studies | 18 | 2019 | 17561 | 0.250 |
Why?
| | Infant, Premature | 5 | 2019 | 635 | 0.250 |
Why?
| | Adolescent | 23 | 2026 | 22826 | 0.250 |
Why?
| | Humans | 52 | 2026 | 147306 | 0.240 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2015 | 297 | 0.240 |
Why?
| | Ultrasonography, Prenatal | 2 | 2009 | 295 | 0.240 |
Why?
| | Female | 37 | 2026 | 80081 | 0.240 |
Why?
| | Infant, Newborn | 15 | 2019 | 6543 | 0.230 |
Why?
| | Monosomy | 1 | 2004 | 10 | 0.210 |
Why?
| | Heart Transplantation | 3 | 2017 | 682 | 0.210 |
Why?
| | Heart Septum | 1 | 2004 | 27 | 0.210 |
Why?
| | Vascular Stiffness | 2 | 2020 | 488 | 0.210 |
Why?
| | Aortic Valve Insufficiency | 1 | 2004 | 43 | 0.210 |
Why?
| | Appointments and Schedules | 1 | 2025 | 97 | 0.210 |
Why?
| | Sex Chromosome Disorders | 1 | 2004 | 27 | 0.210 |
Why?
| | Tanzania | 2 | 2014 | 74 | 0.210 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2016 | 248 | 0.210 |
Why?
| | Mosaicism | 1 | 2004 | 73 | 0.200 |
Why?
| | Mitral Valve | 3 | 2016 | 96 | 0.200 |
Why?
| | Medical Errors | 1 | 2025 | 119 | 0.200 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 124 | 0.190 |
Why?
| | Anastomosis, Surgical | 2 | 2007 | 167 | 0.190 |
Why?
| | Hospitalization | 1 | 2014 | 2496 | 0.190 |
Why?
| | Incidence | 4 | 2019 | 2954 | 0.190 |
Why?
| | Quality Improvement | 2 | 2025 | 1321 | 0.190 |
Why?
| | Pulmonary Veins | 2 | 2016 | 112 | 0.180 |
Why?
| | Aortic Coarctation | 1 | 2002 | 78 | 0.170 |
Why?
| | Treatment Outcome | 7 | 2019 | 11947 | 0.170 |
Why?
| | Comorbidity | 2 | 2017 | 1672 | 0.160 |
Why?
| | Vascular Resistance | 2 | 2019 | 372 | 0.160 |
Why?
| | Adaptation, Psychological | 1 | 2026 | 736 | 0.160 |
Why?
| | Cardiomyopathies | 1 | 2004 | 339 | 0.160 |
Why?
| | Follow-Up Studies | 7 | 2019 | 5478 | 0.160 |
Why?
| | Infant | 12 | 2019 | 10195 | 0.150 |
Why?
| | Aorta, Thoracic | 2 | 2018 | 288 | 0.150 |
Why?
| | Risk Factors | 6 | 2019 | 11017 | 0.140 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 196 | 0.140 |
Why?
| | Tilt-Table Test | 1 | 1998 | 8 | 0.140 |
Why?
| | Syncope, Vasovagal | 1 | 1998 | 6 | 0.140 |
Why?
| | Blood Flow Velocity | 2 | 2014 | 422 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2004 | 616 | 0.140 |
Why?
| | Colorado | 6 | 2018 | 4591 | 0.130 |
Why?
| | Reference Values | 2 | 2017 | 800 | 0.130 |
Why?
| | Reproducibility of Results | 5 | 2018 | 3448 | 0.130 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 178 | 0.130 |
Why?
| | Sodium Chloride | 1 | 1998 | 138 | 0.130 |
Why?
| | Lung Diseases | 2 | 2018 | 787 | 0.120 |
Why?
| | Parents | 1 | 2026 | 1428 | 0.120 |
Why?
| | Image Enhancement | 2 | 2015 | 201 | 0.120 |
Why?
| | Infant Mortality | 1 | 2018 | 129 | 0.120 |
Why?
| | Laboratories, Hospital | 1 | 2016 | 14 | 0.120 |
Why?
| | Fluid Therapy | 1 | 1998 | 156 | 0.120 |
Why?
| | Sensitivity and Specificity | 4 | 2015 | 2017 | 0.120 |
Why?
| | Feasibility Studies | 2 | 2013 | 1147 | 0.120 |
Why?
| | Postoperative Care | 1 | 2018 | 299 | 0.110 |
Why?
| | Electrocardiography | 2 | 2012 | 675 | 0.110 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 289 | 0.110 |
Why?
| | Quality of Life | 2 | 2026 | 3246 | 0.110 |
Why?
| | Body Mass Index | 1 | 2004 | 2470 | 0.110 |
Why?
| | Efficiency, Organizational | 1 | 2016 | 141 | 0.110 |
Why?
| | Young Adult | 6 | 2020 | 14437 | 0.110 |
Why?
| | Pediatrics | 2 | 2016 | 1139 | 0.110 |
Why?
| | Prospective Studies | 8 | 2020 | 8166 | 0.110 |
Why?
| | Acute Disease | 2 | 2015 | 1049 | 0.110 |
Why?
| | Mitral Valve Stenosis | 1 | 2014 | 20 | 0.110 |
Why?
| | Neoplasms | 2 | 2025 | 2946 | 0.110 |
Why?
| | Workload | 1 | 2016 | 172 | 0.100 |
Why?
| | Causality | 1 | 2014 | 129 | 0.100 |
Why?
| | Pulmonary Circulation | 1 | 2016 | 434 | 0.100 |
Why?
| | Program Evaluation | 1 | 2018 | 952 | 0.100 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2014 | 71 | 0.100 |
Why?
| | Coronary Angiography | 1 | 2016 | 329 | 0.100 |
Why?
| | Respiration, Artificial | 2 | 2019 | 717 | 0.100 |
Why?
| | Severity of Illness Index | 3 | 2017 | 2974 | 0.100 |
Why?
| | Anthracyclines | 1 | 2013 | 49 | 0.100 |
Why?
| | Time Factors | 4 | 2018 | 7173 | 0.100 |
Why?
| | Arterial Pressure | 1 | 2014 | 134 | 0.100 |
Why?
| | Cardiology | 1 | 2016 | 364 | 0.090 |
Why?
| | Survival Rate | 1 | 2018 | 2110 | 0.090 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 190 | 0.090 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2015 | 358 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 754 | 0.080 |
Why?
| | Isolated Noncompaction of the Ventricular Myocardium | 1 | 2010 | 4 | 0.080 |
Why?
| | Death, Sudden | 1 | 2010 | 26 | 0.080 |
Why?
| | Prognosis | 2 | 2017 | 4384 | 0.080 |
Why?
| | Observer Variation | 3 | 2017 | 358 | 0.080 |
Why?
| | Obesity | 1 | 2004 | 3149 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2026 | 6164 | 0.080 |
Why?
| | Syncope | 1 | 2010 | 56 | 0.080 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2010 | 59 | 0.080 |
Why?
| | Brachiocephalic Veins | 1 | 2009 | 4 | 0.070 |
Why?
| | Age Factors | 5 | 2017 | 3372 | 0.070 |
Why?
| | Clinical Competence | 1 | 2018 | 1260 | 0.070 |
Why?
| | Predictive Value of Tests | 4 | 2016 | 2133 | 0.070 |
Why?
| | Truncus Arteriosus, Persistent | 1 | 2009 | 7 | 0.070 |
Why?
| | Cross-Sectional Studies | 5 | 2020 | 6011 | 0.070 |
Why?
| | Liver | 1 | 2018 | 1916 | 0.070 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 344 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2012 | 360 | 0.070 |
Why?
| | Disease Progression | 1 | 2017 | 2892 | 0.070 |
Why?
| | Vascular Malformations | 1 | 2009 | 53 | 0.070 |
Why?
| | Rubidium Radioisotopes | 1 | 2008 | 9 | 0.070 |
Why?
| | United States | 4 | 2020 | 16313 | 0.070 |
Why?
| | Atrial Septum | 1 | 2007 | 3 | 0.070 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2008 | 45 | 0.070 |
Why?
| | Hernia, Diaphragmatic | 1 | 2008 | 67 | 0.070 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2009 | 138 | 0.060 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 525 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 199 | 0.060 |
Why?
| | Coronary Vessel Anomalies | 1 | 2006 | 38 | 0.060 |
Why?
| | Ontario | 2 | 2016 | 91 | 0.060 |
Why?
| | ROC Curve | 2 | 2018 | 626 | 0.060 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 12 | 0.060 |
Why?
| | Exercise Test | 2 | 2018 | 636 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2008 | 347 | 0.050 |
Why?
| | Chromosomes, Human, Y | 1 | 2004 | 37 | 0.050 |
Why?
| | Chromosomes, Human, X | 1 | 2004 | 78 | 0.050 |
Why?
| | Mitral Valve Insufficiency | 1 | 2004 | 69 | 0.050 |
Why?
| | Ultrasonography | 3 | 2015 | 795 | 0.050 |
Why?
| | Gestational Age | 2 | 2019 | 997 | 0.050 |
Why?
| | Lung | 2 | 2015 | 4141 | 0.050 |
Why?
| | Adult | 7 | 2026 | 41406 | 0.050 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2015 | 37 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1747 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 1598 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 568 | 0.040 |
Why?
| | Logistic Models | 2 | 2019 | 2142 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2025 | 566 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 46 | 0.040 |
Why?
| | Coronary Circulation | 1 | 2020 | 134 | 0.040 |
Why?
| | Reoperation | 1 | 2002 | 644 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 196 | 0.040 |
Why?
| | Mutation | 1 | 2010 | 4130 | 0.040 |
Why?
| | Longevity | 1 | 2020 | 178 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2004 | 607 | 0.030 |
Why?
| | Vena Cava, Superior | 2 | 2009 | 25 | 0.030 |
Why?
| | Heart Failure | 1 | 2012 | 2334 | 0.030 |
Why?
| | Qualitative Research | 1 | 2026 | 1735 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 1998 | 43 | 0.030 |
Why?
| | Medical History Taking | 1 | 2018 | 119 | 0.030 |
Why?
| | Biomechanical Phenomena | 2 | 2015 | 873 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 1998 | 198 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 351 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2026 | 1174 | 0.030 |
Why?
| | Aorta | 1 | 2020 | 443 | 0.030 |
Why?
| | Angiography | 2 | 2009 | 209 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 245 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3980 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 2018 | 182 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 545 | 0.030 |
Why?
| | Autopsy | 1 | 2016 | 96 | 0.030 |
Why?
| | Ventricular Septum | 1 | 2015 | 8 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2020 | 1145 | 0.030 |
Why?
| | Pregnancy | 2 | 2007 | 7276 | 0.030 |
Why?
| | Indiana | 1 | 2015 | 38 | 0.030 |
Why?
| | Computer Systems | 1 | 2014 | 55 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 94 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2016 | 538 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 156 | 0.030 |
Why?
| | Schools, Medical | 1 | 2015 | 159 | 0.020 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 196 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2015 | 494 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2018 | 697 | 0.020 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2013 | 141 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2012 | 59 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1912 | 0.020 |
Why?
| | Registries | 1 | 2020 | 2434 | 0.020 |
Why?
| | Homeobox Protein Nkx-2.5 | 1 | 2010 | 6 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1518 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 571 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1504 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 3029 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 852 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 414 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 633 | 0.020 |
Why?
| | Incidental Findings | 1 | 2009 | 82 | 0.020 |
Why?
| | Mass Screening | 1 | 2017 | 1375 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1093 | 0.020 |
Why?
| | Ligation | 1 | 2008 | 91 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1550 | 0.020 |
Why?
| | Obstetric Surgical Procedures | 1 | 2007 | 6 | 0.020 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2008 | 68 | 0.020 |
Why?
| | Rare Diseases | 1 | 2008 | 116 | 0.020 |
Why?
| | Echocardiography, Transesophageal | 1 | 2008 | 132 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 726 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2009 | 251 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2175 | 0.020 |
Why?
| | Catheterization | 1 | 2007 | 184 | 0.020 |
Why?
| | Preoperative Care | 1 | 2009 | 381 | 0.020 |
Why?
| | Aortic Valve | 1 | 2009 | 364 | 0.010 |
Why?
| | Motion | 1 | 2006 | 95 | 0.010 |
Why?
| | Models, Molecular | 1 | 2010 | 1606 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 2006 | 97 | 0.010 |
Why?
| | Chronic Disease | 1 | 2008 | 1845 | 0.010 |
Why?
| | Aged | 1 | 2004 | 26516 | 0.000 |
Why?
|
|
Younoszai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|